A message from the new Editor-in-Chief by unknown
I feel honoured to take over as Editor-in-Chief of the British
Journal of Cancer. Following the untimely death last June of Ged
Adams (see obituary Br J Cancer 78: 281), Peter Twentyman
kindly stepped into the breach to act as editor until a long-term
appointment could be made. Peter had been Editor-in-Chief prior
to Ged, and it will be difficult to match the dedication of these two
fine colleagues and friends.
The  British Journal of Cancer will continue to serve the
research community across a broad swathe of exciting develop-
ments in clinical and experimental cancer research. Although
based in the UK as the clinical and scientific journal of the Cancer
Research Campaign, the journal welcomes contributions world-
wide, as can be seen from the contents of this issue. The impor-
tance and significance of the work it publishes is reflected in its
international subscriptions and a readership predominantly outside
the UK. The editorial team are discussing how the subjects within
cancer research might be better classified, and we shall continue to
present and review whatever is important in research on the under-
standing, diagnosis, treatment and prevention of cancer.
My own field of study is viral oncology and cancers related to
AIDS. Oncogenic viruses have given us deep insight into molec-
ular carcinogenesis; the discovery of oncogenes and p53 protein
came through the study of viruses, for instance. Moreover, some
17% of human cancer is attributable to infections especially in
developing countries, which offers potential for prevention
through vaccination and screening. However, I can assure you that
the British Journal of Cancer is not about to become a journal of
infectious disease! We shall publish the best of all cancer research.
Robin A Weiss
University College London
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